Journal of Ovarian Research

(The TQCC of Journal of Ovarian Research is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-08-01 to 2023-08-01.)
Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis115
Circular RNAs in cancer: new insights into functions and implications in ovarian cancer95
Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review91
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective60
Ovarian cancer stem cells and targeted therapy59
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review49
BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases49
YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells47
miR-552 promotes ovarian cancer progression by regulating PTEN pathway46
Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells45
Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer44
Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age44
Withaferin A: a potential therapeutic agent against COVID-19 infection37
Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review37
Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women35
circRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382-5p/PRPF8 axis33
Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis32
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells31
Therapeutic role of curcumin and its novel formulations in gynecological cancers30
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer30
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized30
Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway28
Long non-coding RNAs in ovarian granulosa cells28
Ovary does harbor stem cells - size of the cells matter!26
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells25
Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols25
MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer25
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer25
The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ24
Functional activities of beta-glucans in the prevention or treatment of cervical cancer24
LINC01094/miR-577 axis regulates the progression of ovarian cancer24
Adipocytes: active facilitators in epithelial ovarian cancer progression?24
Recent trends in stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review23
Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis23
Anti-tumor activities of probiotics in cervical cancer23
Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study22
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer22
Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review22
Whole-exome sequencing in patients with premature ovarian insufficiency: early detection and early intervention22
Association between morphologic grading and implantation rate of Euploid blastocyst21
Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer21
Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses20
Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer20
MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ20
The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect19
Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase19
An overview of FSH-FSHR biology and explaining the existing conundrums19
A novel EIF4ENIF1 mutation associated with a diminished ovarian reserve and premature ovarian insufficiency identified by whole-exome sequencing19
Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD118
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis18
Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models17
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells17
Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer17
Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis17
Effects of metformin and Exenatide on insulin resistance and AMPKα-SIRT1 molecular pathway in PCOS rats17
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging17
Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL117
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A17
The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis17
Decreased ovarian function and autophagy gene methylation in aging rats16
Ovarian endometrioma – a possible finding in adolescent girls and young women: a mini-review16
RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis16
Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study16
Prediction of the treatment response in ovarian cancer: a ctDNA approach16
Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer16
RETRACTED ARTICLE: Long non-coding RNA PTPRG-AS1 promotes cell tumorigenicity in epithelial ovarian cancer by decoying microRNA-545-3p and consequently enhancing HDAC4 expression15
Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis15
Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis15
Comparison of methods for quantifying primordial follicles in the mouse ovary15
Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients15
Influence of marital status on overall survival in patients with ovarian serous carcinoma: finding from the surveillance epidemiology and end results (SEER) database15
Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from China15
Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis14
Estrogen enhances the proliferation and migration of ovarian cancer cells by activating transient receptor potential channel C314
Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses14
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?14
Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer13
FMRpolyG accumulates in FMR1 premutation granulosa cells13
Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis13
Abnormal expression of HSP70 may contribute to PCOS pathology13
RETRACTED ARTICLE: LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration13
Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer13
Transcriptomics of cumulus cells – a window into oocyte maturation in humans13
S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin13
Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling13
miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcino13
The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients12
Vitrification freezing of large ovarian tissue in the human body12
MicroRNA-145-5p regulates the proliferation of epithelial ovarian cancer cells via targeting SMAD412
Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer12
Long non-coding RNA THOR promotes ovarian Cancer cells progression via IL-6/STAT3 pathway12
Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis12
Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome12
The role of oxidative stress in ovarian aging: a review12
Rare homozygous mutation in TUBB8 associated with oocyte maturation defect-2 in a consanguineous mating family12
Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature12
H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis12
Characteristics and treatment results of recurrence in adult-type granulosa cell tumor of ovary11
Telomere length in granulosa cells and leukocytes: a potential marker of female fertility? A systematic review of the literature11
A combination of spearmint and flaxseed extract improved endocrine and histomorphology of ovary in experimental PCOS11
The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal‐weight population11
Systematic analysis of ovarian cancer platinum-resistance mechanisms via text mining11
Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments11
RETRACTED ARTICLE: LncRNA miR503HG interacts with miR-31-5p through multiple ways to regulate cancer cell invasion and migration in ovarian cancer11
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study11
LncRNA TONSL-AS1 regulates miR-490-3p/CDK1 to affect ovarian epithelial carcinoma cell proliferation11
Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?11
CACNA1C is a prognostic predictor for patients with ovarian cancer11
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer11
Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1/Akt in granulosa cells of PCOS11
Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study11
LncRNA HOTAIRM1, miR-433-5p and PIK3CD function as a ceRNA network to exacerbate the development of PCOS11
UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway11
Alteration of tumor associated neutrophils by PIK3CA expression in endometrial carcinoma from TCGA data11
Comparison of the predictive performance of risk of malignancy indexes 1–4, HE4 and risk of malignancy algorithm in the triage of adnexal masses11
Impact of the addition of Early Embryo Viability Assessment to morphological evaluation on the accuracy of embryo selection on day 3 or day 5: a retrospective analysis11
A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer10
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications10
LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis10
Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression10
Identification of WTAP-related genes by weighted gene co-expression network analysis in ovarian cancer10
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing10
MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle arrest in human cov434 cells by targeting FGD410
Adverse reproductive health outcomes in a cohort of young women with breast cancer exposed to systemic treatments10
Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition10
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma10
Targeting purine metabolism in ovarian cancer10
Effect of Endometrioma cystectomy on cytokines of follicular fluid and IVF outcomes10
Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)10
Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy10
The role of MMP-14 in ovarian cancer: a systematic review10
LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p10
Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway10
LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation10
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer10
Lipid droplets in granulosa cells are correlated with reduced pregnancy rates10
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study10
Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer10
miR-145 inhibits mitochondrial function of ovarian cancer by targeting ARL5B10
Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-310
Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice10
Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience9
Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA9
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats9
MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer9
Development and validation of circulating CA125 prediction models in postmenopausal women9
Long-term multidisciplinary integrative therapy management resulted in favorable outcomes for ovarian cancer during pregnancy: a case report and literature review9
Age-related decline in the expression of GDF9 and BMP15 genes in follicle fluid and granulosa cells derived from poor ovarian responders9
Construction autophagy-related prognostic risk signature to facilitate survival prediction, individual treatment and biomarker excavation of epithelial ovarian cancer patients9
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer9
Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a ret9
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer9
Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer9
Aged mice ovaries harbor stem cells and germ cell nests but fail to form follicles9
Berberine inhibited metastasis through miR-145/MMP16 axis in vitro9
p38β - MAPK11 and its role in female cancers9
Mutation analysis of the TUBB8 gene in primary infertile women with oocyte maturation arrest9
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment9
HVEM/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions9
Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors9
Pure dysgerminoma of the ovary: CT and MRI features with pathological correlation in 13 tumors9
Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors9
Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression9
Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer9
Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis9
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report8
Integrative analysis of transcription factors and microRNAs in ovarian cancer cell spheroids8
Role of different non-coding RNAs as ovarian cancer biomarkers8
Trophectoderm biopsy of blastocysts for a preimplantation genetic test does not affect serum β-hCG levels in early pregnancy: a study using propensity score matching8
Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?8
Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors8
Effect of blastocyst morphology and developmental speed on transfer strategy for grade “C” blastocyst in vitrified‐warmed cycles8
LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis8
Performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis8
Association between atypical endometriosis and ovarian malignancies in the real world8
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo8
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer8
Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA1258